The global continuous peripheral nerve block (cPNB) catheters market size was estimated at USD 181.4 million in 2017. It is expected to expand at a CAGR of 6.2% over the forecast period. Growing geriatric population is translating into staggering orthopedic procedure volume, which in turn is fueling the demand for postoperative pain management solutions. In addition, cPNBs are increasingly replacing other regional anesthesia techniques applicable for major orthopedic surgeries. Growing surgery volume coupled with soaring need for effective postoperative care is one of the key trends stoking market growth.
Spiraling number of joint replacements and arthroplasties over the last decade can be attributed to the rising prevalence of osteoarthritis, which is the most common joint disorder. According to the International Association for the Study of Pain, around 10 to 15 % of the total population worldwide suffered from symptomatic osteoarthritis in 2016. Aging cohort and rising prevalence of osteoarthritis are the major factors responsible for the continual surge in the number of orthopedic surgeries around the world.
CPNB catheters also find application in case of major extremity amputations. Lower extremity amputations, driven by diabetic foot ulceration, form a significant number of cases. According to the International Diabetes Federation, the global diabetes population is estimated to rise from 424.9 million in 2017 to 628.6 million by 2045. The upward trend in the volume of amputations, across the world, is expected to propel the market.
Post-operative discomfort is one of the major problems experienced by patients who have undergone joint replacements or arthroplasties and limb amputations. Around one-third of patients experience moderate-to-severe postoperative pain after ambulatory surgery. Combatting this with administration of long-acting opioids has been associated with various side effects, such as nausea, vomiting, and disturbance of sleep. In contrast, use of cPNB catheters for regional anesthesia yields better postsurgical outcomes as well as minimizes side-effects of long-acting opioids. Thus, decreasing preference for opioid use in pain management is responsible for accelerating overall growth of catheters.
On the basis of insertion technique, the ultrasound segment held the largest share of 48.2% in the market. This can be attributed to associated advantages including improved block quality, faster and longer block duration, and need for lower dose of local anesthetic. This technique is being increasingly adopted for pediatric regional anesthesia owing to lower pain index associated with ultrasound-guided insertion.
On the other hand, the nerve stimulation segment is poised to register a sluggish rate of 1.9% over the forecast period. This being the oldest available technology (after blind advancement) for catheter placement is slowly becoming outdated due to introduction of new advanced technologies such as ultrasound-guided catheter placement.
Lower extremity surgeries held a larger share in the cPNB catheters market owing to increasing number of procedures involving the use of these devices. Effective post-operative care along with rise in lower-limb surgeries has a considerable impact on the overall postoperative outcome in terms of decreased hospital stay, faster mobilization, less postoperative nausea, and lower incidence of readmissions.
cPNB catheters are increasingly being employed for effective pain management in major upper limb surgeries, including total shoulder replacement, rotator cuff repair, and elbow replacements that involve chronic post-operative pain. This trend is causing the upper extremity surgeries segment to expand at a steady rate during the forecast period.
The ambulatory surgical centers segment is likely to witness an exponential growth rate of 7.2% over the forecast period. Advantages of day-care surgery centers include shorter waiting list, quicker discharge, reduced overall procedural cost, and treatment for higher number of patients. With healthcare expenditure burden in developed countries and rising awareness regarding merits of these centers, the number of ASCs is projected to increase. This, in turn, will trigger the uptake of cPNB catheters.
Hospitals held the dominant share of 58.5% in the market.Technologically advanced medical devices are being extensively used in hospitals to deliver better patient care. Treatment in hospitals come with a good amount of reimbursement. Generally, they are the only healthcare providers in developing countries, which lack ambulatory surgical centers.
North America held the largest share and was valued at USD 96.3 million in 2017. This can be attributed to increasing target population coupled with growing prevalence of lifestyle-associated diseases, such as diabetes and orthopedic conditions. Other factors contributing to the overall revenue generation are a well-developed reimbursement structure and growing number of day-care surgery centers.
The Europe region is anticipated to post a noteworthy CAGR of 6.4% over the forecast period. Europe records the highest number of surgeries, which supports usage of continuous peripheral nerve block catheters to manage postoperative discomfort. The European Society of Regional Anaesthesia & Pain Therapy (ESRA) recommends use of peripheral nerve blocks for acute postsurgical pain in adult as well as pediatric patients, the latter receiving a higher percentage of cPNBs. Another factor boosting the adoption of these devices is increase in day care/ambulatory surgeries across the region.
The market is highly competitive in nature, with a limited number of players accounting for the majority market share. Notable participants such as B. Braun Melsungen AG; Teleflex Incorporated; Halyard Health, Inc.; Pajunk GMBH; and Vygon, represent nearly 65.0% of the market. Players are focusing on development of technologically advanced devices, which offer comfort to its users. New product development, strategic alliances, promotional activities, and acquisitions are instrumental in keeping the market rivalry high.
Market leaders, Pajunk and B. Braun being the first to introduce catheter-over-needle technology, are regarded market innovators. Risks and costs associated with development of novel products are increasing over time and market leaders are better positioned with required resources to carry out R&D activities. For instance, B. Braun was the first company to introduce catheter-over-needle technology for performing nerve blocks, thereby gaining competitive advantage over other players.
Base year for estimation
Actual estimates/Historical data
2014 - 2016
Revenue in USD Million and CAGR from 2018 to 2025
North America, Europe, Asia Pacific, Latin America, Middle East & Africa
U.S., Canada, U.K., Germany, France, Italy, Sweden, Denmark, Norway, Finland, Japan, China, India, Australia, New Zealand, Singapore, Thailand, Korea, Hong Kong, Taiwan, Brazil, Mexico, Chile, South Africa, Saudi Arabia, Turkey, Israel, Kuwait
Revenue forecast, company share, competitive landscape, growth factors and trends
15% free customization scope (equivalent to 5 analyst working days)
If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization
This report forecasts revenue growth at global, regional, & country levels and provides an analysis of the industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global continuous peripheral nerve block (cPNB) catheters market report on the basis of insertion technique, indication, end use, and region:
Insertion Technique Outlook (Revenue, USD Million, 2014 - 2025)
Indication Outlook (Revenue, USD Million, 2014 - 2025)
Upper Extremity Surgery
Lower Extremity Surgery
End Use Outlook (Revenue, USD Million, 2014 - 2025)
Ambulatory Surgical Centers
Regional Outlook (Revenue, USD Million, 2014 - 2025)
Middle East and Africa
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.